nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Musculoskeletal pain—Vincristine—muscle cancer	0.0205	0.0205	CcSEcCtD
Zanamivir—Lymphopenia—Doxorubicin—muscle cancer	0.0166	0.0166	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.0148	0.0148	CcSEcCtD
Zanamivir—Lung disorder—Methotrexate—muscle cancer	0.0139	0.0139	CcSEcCtD
Zanamivir—Dehydration—Vincristine—muscle cancer	0.0137	0.0137	CcSEcCtD
Zanamivir—Neutropenia—Dactinomycin—muscle cancer	0.0133	0.0133	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.0126	0.0126	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Etoposide—muscle cancer	0.0123	0.0123	CcSEcCtD
Zanamivir—Lung disorder—Doxorubicin—muscle cancer	0.012	0.012	CcSEcCtD
Zanamivir—Neutropenia—Vincristine—muscle cancer	0.0119	0.0119	CcSEcCtD
Zanamivir—Erythema multiforme—Dactinomycin—muscle cancer	0.0107	0.0107	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.0107	0.0107	CcSEcCtD
Zanamivir—Chills—Dactinomycin—muscle cancer	0.0102	0.0102	CcSEcCtD
Zanamivir—Bronchospasm—Etoposide—muscle cancer	0.0101	0.0101	CcSEcCtD
Zanamivir—Hallucination—Vincristine—muscle cancer	0.0101	0.0101	CcSEcCtD
Zanamivir—Delirium—Doxorubicin—muscle cancer	0.00988	0.00988	CcSEcCtD
Zanamivir—Neutropenia—Etoposide—muscle cancer	0.00961	0.00961	CcSEcCtD
Zanamivir—Ill-defined disorder—Dactinomycin—muscle cancer	0.00918	0.00918	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00909	0.00909	CcSEcCtD
Zanamivir—Malaise—Dactinomycin—muscle cancer	0.00892	0.00892	CcSEcCtD
Zanamivir—Musculoskeletal pain—Doxorubicin—muscle cancer	0.0086	0.0086	CcSEcCtD
Zanamivir—Myalgia—Dactinomycin—muscle cancer	0.00843	0.00843	CcSEcCtD
Zanamivir—Discomfort—Dactinomycin—muscle cancer	0.00832	0.00832	CcSEcCtD
Zanamivir—Influenza like illness—Doxorubicin—muscle cancer	0.00825	0.00825	CcSEcCtD
Zanamivir—Agitation—Vincristine—muscle cancer	0.00813	0.00813	CcSEcCtD
Zanamivir—Infection—Dactinomycin—muscle cancer	0.00802	0.00802	CcSEcCtD
Zanamivir—Erythema multiforme—Etoposide—muscle cancer	0.00778	0.00778	CcSEcCtD
Zanamivir—Anorexia—Dactinomycin—muscle cancer	0.0077	0.0077	CcSEcCtD
Zanamivir—Convulsion—Vincristine—muscle cancer	0.00766	0.00766	CcSEcCtD
Zanamivir—Myalgia—Vincristine—muscle cancer	0.00753	0.00753	CcSEcCtD
Zanamivir—Chills—Etoposide—muscle cancer	0.00738	0.00738	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00736	0.00736	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00736	0.00736	CcSEcCtD
Zanamivir—Anaphylactic shock—Vincristine—muscle cancer	0.00722	0.00722	CcSEcCtD
Zanamivir—Infection—Vincristine—muscle cancer	0.00717	0.00717	CcSEcCtD
Zanamivir—Decreased appetite—Dactinomycin—muscle cancer	0.00702	0.00702	CcSEcCtD
Zanamivir—Fatigue—Dactinomycin—muscle cancer	0.00696	0.00696	CcSEcCtD
Zanamivir—Pain—Dactinomycin—muscle cancer	0.00691	0.00691	CcSEcCtD
Zanamivir—Anorexia—Vincristine—muscle cancer	0.00688	0.00688	CcSEcCtD
Zanamivir—Feeling abnormal—Dactinomycin—muscle cancer	0.00666	0.00666	CcSEcCtD
Zanamivir—Ill-defined disorder—Etoposide—muscle cancer	0.00665	0.00665	CcSEcCtD
Zanamivir—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0066	0.0066	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00657	0.00657	CcSEcCtD
Zanamivir—Increased appetite—Doxorubicin—muscle cancer	0.00657	0.00657	CcSEcCtD
Zanamivir—Malaise—Etoposide—muscle cancer	0.00646	0.00646	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00642	0.00642	CcSEcCtD
Zanamivir—Abdominal pain—Dactinomycin—muscle cancer	0.00638	0.00638	CcSEcCtD
Zanamivir—Body temperature increased—Dactinomycin—muscle cancer	0.00638	0.00638	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00637	0.00637	CcSEcCtD
Zanamivir—Loss of consciousness—Etoposide—muscle cancer	0.0063	0.0063	CcSEcCtD
Zanamivir—Decreased appetite—Vincristine—muscle cancer	0.00627	0.00627	CcSEcCtD
Zanamivir—Cough—Etoposide—muscle cancer	0.00625	0.00625	CcSEcCtD
Zanamivir—Fatigue—Vincristine—muscle cancer	0.00622	0.00622	CcSEcCtD
Zanamivir—Convulsion—Etoposide—muscle cancer	0.00621	0.00621	CcSEcCtD
Zanamivir—Pain—Vincristine—muscle cancer	0.00617	0.00617	CcSEcCtD
Zanamivir—Asthma—Methotrexate—muscle cancer	0.00616	0.00616	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00606	0.00606	CcSEcCtD
Zanamivir—Discomfort—Etoposide—muscle cancer	0.00602	0.00602	CcSEcCtD
Zanamivir—Face oedema—Doxorubicin—muscle cancer	0.00596	0.00596	CcSEcCtD
Zanamivir—Hypersensitivity—Dactinomycin—muscle cancer	0.00595	0.00595	CcSEcCtD
Zanamivir—Gastrointestinal pain—Vincristine—muscle cancer	0.0059	0.0059	CcSEcCtD
Zanamivir—Confusional state—Etoposide—muscle cancer	0.00589	0.00589	CcSEcCtD
Zanamivir—Anaphylactic shock—Etoposide—muscle cancer	0.00585	0.00585	CcSEcCtD
Zanamivir—Infection—Etoposide—muscle cancer	0.00581	0.00581	CcSEcCtD
Zanamivir—Asthenia—Dactinomycin—muscle cancer	0.00579	0.00579	CcSEcCtD
Zanamivir—Neutropenia—Methotrexate—muscle cancer	0.00576	0.00576	CcSEcCtD
Zanamivir—Dehydration—Doxorubicin—muscle cancer	0.00574	0.00574	CcSEcCtD
Zanamivir—Body temperature increased—Vincristine—muscle cancer	0.0057	0.0057	CcSEcCtD
Zanamivir—Abdominal pain—Vincristine—muscle cancer	0.0057	0.0057	CcSEcCtD
Zanamivir—Skin disorder—Etoposide—muscle cancer	0.00568	0.00568	CcSEcCtD
Zanamivir—Anorexia—Etoposide—muscle cancer	0.00557	0.00557	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00555	0.00555	CcSEcCtD
Zanamivir—Diarrhoea—Dactinomycin—muscle cancer	0.00553	0.00553	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00544	0.00544	CcSEcCtD
Zanamivir—Influenza—Doxorubicin—muscle cancer	0.00533	0.00533	CcSEcCtD
Zanamivir—Asthma—Doxorubicin—muscle cancer	0.00533	0.00533	CcSEcCtD
Zanamivir—Hypersensitivity—Vincristine—muscle cancer	0.00532	0.00532	CcSEcCtD
Zanamivir—Dyspnoea—Etoposide—muscle cancer	0.00521	0.00521	CcSEcCtD
Zanamivir—Asthenia—Vincristine—muscle cancer	0.00518	0.00518	CcSEcCtD
Zanamivir—Vomiting—Dactinomycin—muscle cancer	0.00514	0.00514	CcSEcCtD
Zanamivir—Bronchitis—Doxorubicin—muscle cancer	0.00513	0.00513	CcSEcCtD
Zanamivir—Rash—Dactinomycin—muscle cancer	0.00509	0.00509	CcSEcCtD
Zanamivir—Decreased appetite—Etoposide—muscle cancer	0.00508	0.00508	CcSEcCtD
Zanamivir—Fatigue—Etoposide—muscle cancer	0.00504	0.00504	CcSEcCtD
Zanamivir—Pain—Etoposide—muscle cancer	0.005	0.005	CcSEcCtD
Zanamivir—Neutropenia—Doxorubicin—muscle cancer	0.00499	0.00499	CcSEcCtD
Zanamivir—Haemoglobin—Methotrexate—muscle cancer	0.00495	0.00495	CcSEcCtD
Zanamivir—Diarrhoea—Vincristine—muscle cancer	0.00494	0.00494	CcSEcCtD
Zanamivir—Haemorrhage—Methotrexate—muscle cancer	0.00493	0.00493	CcSEcCtD
Zanamivir—Feeling abnormal—Etoposide—muscle cancer	0.00482	0.00482	CcSEcCtD
Zanamivir—Nausea—Dactinomycin—muscle cancer	0.0048	0.0048	CcSEcCtD
Zanamivir—Gastrointestinal pain—Etoposide—muscle cancer	0.00478	0.00478	CcSEcCtD
Zanamivir—Dizziness—Vincristine—muscle cancer	0.00477	0.00477	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00471	0.00471	CcSEcCtD
Zanamivir—Erythema multiforme—Methotrexate—muscle cancer	0.00466	0.00466	CcSEcCtD
Zanamivir—Urticaria—Etoposide—muscle cancer	0.00464	0.00464	CcSEcCtD
Zanamivir—Abdominal pain—Etoposide—muscle cancer	0.00462	0.00462	CcSEcCtD
Zanamivir—Body temperature increased—Etoposide—muscle cancer	0.00462	0.00462	CcSEcCtD
Zanamivir—Vomiting—Vincristine—muscle cancer	0.00459	0.00459	CcSEcCtD
Zanamivir—Rash—Vincristine—muscle cancer	0.00455	0.00455	CcSEcCtD
Zanamivir—Dermatitis—Vincristine—muscle cancer	0.00455	0.00455	CcSEcCtD
Zanamivir—Headache—Vincristine—muscle cancer	0.00452	0.00452	CcSEcCtD
Zanamivir—Sinusitis—Doxorubicin—muscle cancer	0.00446	0.00446	CcSEcCtD
Zanamivir—Chills—Methotrexate—muscle cancer	0.00442	0.00442	CcSEcCtD
Zanamivir—Hypersensitivity—Etoposide—muscle cancer	0.00431	0.00431	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—muscle cancer	0.00429	0.00429	CcSEcCtD
Zanamivir—Nausea—Vincristine—muscle cancer	0.00429	0.00429	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—muscle cancer	0.00427	0.00427	CcSEcCtD
Zanamivir—Asthenia—Etoposide—muscle cancer	0.00419	0.00419	CcSEcCtD
Zanamivir—Erythema multiforme—Doxorubicin—muscle cancer	0.00403	0.00403	CcSEcCtD
Zanamivir—Diarrhoea—Etoposide—muscle cancer	0.004	0.004	CcSEcCtD
Zanamivir—Ill-defined disorder—Methotrexate—muscle cancer	0.00398	0.00398	CcSEcCtD
Zanamivir—Malaise—Methotrexate—muscle cancer	0.00387	0.00387	CcSEcCtD
Zanamivir—Dizziness—Etoposide—muscle cancer	0.00387	0.00387	CcSEcCtD
Zanamivir—Chills—Doxorubicin—muscle cancer	0.00383	0.00383	CcSEcCtD
Zanamivir—Arrhythmia—Doxorubicin—muscle cancer	0.00381	0.00381	CcSEcCtD
Zanamivir—Cough—Methotrexate—muscle cancer	0.00374	0.00374	CcSEcCtD
Zanamivir—Convulsion—Methotrexate—muscle cancer	0.00372	0.00372	CcSEcCtD
Zanamivir—Vomiting—Etoposide—muscle cancer	0.00372	0.00372	CcSEcCtD
Zanamivir—Rash—Etoposide—muscle cancer	0.00369	0.00369	CcSEcCtD
Zanamivir—Dermatitis—Etoposide—muscle cancer	0.00368	0.00368	CcSEcCtD
Zanamivir—Headache—Etoposide—muscle cancer	0.00366	0.00366	CcSEcCtD
Zanamivir—Arthralgia—Methotrexate—muscle cancer	0.00365	0.00365	CcSEcCtD
Zanamivir—Myalgia—Methotrexate—muscle cancer	0.00365	0.00365	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00363	0.00363	CcSEcCtD
Zanamivir—Discomfort—Methotrexate—muscle cancer	0.00361	0.00361	CcSEcCtD
Zanamivir—Confusional state—Methotrexate—muscle cancer	0.00353	0.00353	CcSEcCtD
Zanamivir—Anaphylactic shock—Methotrexate—muscle cancer	0.0035	0.0035	CcSEcCtD
Zanamivir—Infection—Methotrexate—muscle cancer	0.00348	0.00348	CcSEcCtD
Zanamivir—Nausea—Etoposide—muscle cancer	0.00347	0.00347	CcSEcCtD
Zanamivir—Ill-defined disorder—Doxorubicin—muscle cancer	0.00345	0.00345	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—muscle cancer	0.00341	0.00341	CcSEcCtD
Zanamivir—Skin disorder—Methotrexate—muscle cancer	0.0034	0.0034	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—muscle cancer	0.00335	0.00335	CcSEcCtD
Zanamivir—Anorexia—Methotrexate—muscle cancer	0.00334	0.00334	CcSEcCtD
Zanamivir—Syncope—Doxorubicin—muscle cancer	0.00333	0.00333	CcSEcCtD
Zanamivir—Loss of consciousness—Doxorubicin—muscle cancer	0.00327	0.00327	CcSEcCtD
Zanamivir—Cough—Doxorubicin—muscle cancer	0.00324	0.00324	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—muscle cancer	0.00322	0.00322	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00319	0.00319	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—muscle cancer	0.00316	0.00316	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—muscle cancer	0.00316	0.00316	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—muscle cancer	0.00315	0.00315	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00314	0.00314	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—muscle cancer	0.00312	0.00312	CcSEcCtD
Zanamivir—Dyspnoea—Methotrexate—muscle cancer	0.00312	0.00312	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—muscle cancer	0.00306	0.00306	CcSEcCtD
Zanamivir—Decreased appetite—Methotrexate—muscle cancer	0.00304	0.00304	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—muscle cancer	0.00303	0.00303	CcSEcCtD
Zanamivir—Fatigue—Methotrexate—muscle cancer	0.00302	0.00302	CcSEcCtD
Zanamivir—Infection—Doxorubicin—muscle cancer	0.00301	0.00301	CcSEcCtD
Zanamivir—Pain—Methotrexate—muscle cancer	0.00299	0.00299	CcSEcCtD
Zanamivir—Shock—Doxorubicin—muscle cancer	0.00298	0.00298	CcSEcCtD
Zanamivir—Skin disorder—Doxorubicin—muscle cancer	0.00294	0.00294	CcSEcCtD
Zanamivir—Anorexia—Doxorubicin—muscle cancer	0.00289	0.00289	CcSEcCtD
Zanamivir—Feeling abnormal—Methotrexate—muscle cancer	0.00289	0.00289	CcSEcCtD
Zanamivir—Gastrointestinal pain—Methotrexate—muscle cancer	0.00286	0.00286	CcSEcCtD
Zanamivir—Urticaria—Methotrexate—muscle cancer	0.00278	0.00278	CcSEcCtD
Zanamivir—Abdominal pain—Methotrexate—muscle cancer	0.00277	0.00277	CcSEcCtD
Zanamivir—Body temperature increased—Methotrexate—muscle cancer	0.00277	0.00277	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Zanamivir—Dyspnoea—Doxorubicin—muscle cancer	0.0027	0.0027	CcSEcCtD
Zanamivir—Decreased appetite—Doxorubicin—muscle cancer	0.00264	0.00264	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—muscle cancer	0.00261	0.00261	CcSEcCtD
Zanamivir—Pain—Doxorubicin—muscle cancer	0.00259	0.00259	CcSEcCtD
Zanamivir—Hypersensitivity—Methotrexate—muscle cancer	0.00258	0.00258	CcSEcCtD
Zanamivir—Asthenia—Methotrexate—muscle cancer	0.00251	0.00251	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—muscle cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Urticaria—Doxorubicin—muscle cancer	0.00241	0.00241	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—muscle cancer	0.0024	0.0024	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—muscle cancer	0.0024	0.0024	CcSEcCtD
Zanamivir—Diarrhoea—Methotrexate—muscle cancer	0.0024	0.0024	CcSEcCtD
Zanamivir—Dizziness—Methotrexate—muscle cancer	0.00232	0.00232	CcSEcCtD
Zanamivir—Hypersensitivity—Doxorubicin—muscle cancer	0.00223	0.00223	CcSEcCtD
Zanamivir—Vomiting—Methotrexate—muscle cancer	0.00223	0.00223	CcSEcCtD
Zanamivir—Rash—Methotrexate—muscle cancer	0.00221	0.00221	CcSEcCtD
Zanamivir—Dermatitis—Methotrexate—muscle cancer	0.00221	0.00221	CcSEcCtD
Zanamivir—Headache—Methotrexate—muscle cancer	0.00219	0.00219	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—muscle cancer	0.00218	0.00218	CcSEcCtD
Zanamivir—Nausea—Methotrexate—muscle cancer	0.00208	0.00208	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—muscle cancer	0.00207	0.00207	CcSEcCtD
Zanamivir—Dizziness—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Zanamivir—Vomiting—Doxorubicin—muscle cancer	0.00193	0.00193	CcSEcCtD
Zanamivir—Rash—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—muscle cancer	0.00191	0.00191	CcSEcCtD
Zanamivir—Headache—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—muscle cancer	0.0018	0.0018	CcSEcCtD
